Medijski sadržaj
- Tweetovi
- Tweetovi i odgovori
- Medijski sadržaj, trenutna stranica.
-
Excited to share research leveraging Neurolign’s Dx 100™ published in Race Car Engineer. The research will be invaluable to support clinicians and engineers in concussion prevention. Check out the full article from Race Car Engineer (March 2020): https://neurolign.com/news/ pic.twitter.com/yybpkQ0Ycy
-
Check out the poster with findings leveraging our Neurolign Dx 100™ at
#ARO2020.pic.twitter.com/0xFhAONQ8S
-
The last three days at the
#BiotechShowcase in San Francisco has been an exciting and productive time for the Neurolign team. Looking forward to future opportunities to enhance the diagnosis and treatment of neurological disorders in 2020 and beyond!pic.twitter.com/I76YstWBpL
-
Neurolign is presenting at Digital Medicine & Medtech Showcase this morning at Parc 55 San Francisco in Balboa at 10 am PT. Join us to find out how Neurolign is creating a revolutionary approach to the assessment and treatment of brain injury and disease.
#BiotechShowcasepic.twitter.com/qUCYnYBR2g
-
Thanks, Biotech! A room full of enthusiasts came out to hear about Neurolign on Monday. Looking forward to tomorrow’s presentation at Parc 55 San Francisco in Balboa at 10:00 am PT.
#BiotechShowcasepic.twitter.com/QgcC3cUdRH
-
Learn more about how Neurolign is dedicated to creating a quantum shift in the diagnosis and treatment of neurodegenerative disease at
#BiotechShowcase from Neurolign’s COO Derek Clark at 3:30 pm PT in Franciscan C. http://neurolign.com/news/ pic.twitter.com/NrZoANTBwJ
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.